医生擅长
医生简介
博士、副研究员。主要从事新型放射性药物研制及临床转化，推动10余种核素探针用于临床。中国核学会放射性药物分会(首届)秘书长 (常务理事、联合创始人)、核化学与放射化学分会第九届理事，中华医学会核医学分会第十届青委。近5年，发表通讯/第一作者SCI论文21篇，申请国家发明专利十余项(4项授权)。获2项国家自然科学基金(1项在研)，2项国家重点研发计划(项目骨干)，北京市自然科学基金(优秀成果)，北京市“科技新星”、优秀人才培养“青年拔尖”，等多个项目支持，在研经费300 余万。
发表论文情况
近3年代表性论文(10 篇)：( †代表共同第一作者，*代表通讯作者)
1. Hua Zhu, Liu Fei, Yan Zhang, Jianhua Yang, Xiaoxia Xu, Xiaoyi Guo, Teli Liu, Nan Li, Lin Zhu, Hank F. Kung*, Zhi Yang*. [18F](2S,4R)-4-Fluoroglutamine as a PET indicator for bone marrow metabolism dysfunctional: From animal experiments to clinical application. Molecular Imaging and Biology. 2019. DOI: 10.1007/s11307-019-01319-4. (Q1, SCI 3.626)
2. Teli Liu†, Chen Liu†, Xiaoxia Xu, Fei Liu, Xiaoyi Guo, Nan Li, Xuejuan Wang, Jianhua Yang, Xing Yang, Hua Zhu*, Zhi Yang*. Preclinical evaluation and primary clinical study of Al18F-PSMA-BCH in PET imaging of prostate cancer. Journal of Nuclear Medicine, 2019, doi:10.2967/jnumed.118.221671. (Q1, SCI 7.439)
3. Fei Liu†, Xiaoxia Xu†, Hua Zhu†, Yan Zhang, Jianhua Yang, Lifang Zhang, Nan Li, Lin Zhu, Hank F. Kung*, Zhi Yang*. PET Imaging of 18F-(2S,4R)4-fluoroglutamine Accumulation in Breast Cancer: from Xenografts to Patients. Molecular Pharmaceutics. 2018, 15 (8), pp 3448-3455. (SCI IF 4.556 Q1 )
4. Feng Wang, Teli Liu, Liqiang Li, Xiaoyi Guo, Dongban Duan, Zhibo Liu, Hua Zhu*, Zhi Yang. Production, Quality Control of next-generation PET radioisotope Iodine-124 and its Thyroid Imaging. J Radio. Nucl. Chem. 2018, 318: 1999-2006. (SCI IF 1.2, Q2)
5. Xiaoyi Guo†, Hua Zhu†, Nina Zhou, Zuhua Chen, Teli Liu, Fei Liu, Xiaoxia Xu, Hongjun Jin, Lin Shen, Jing Gao*, and Zhi Yang*.Non-invasive Detection of HER2 Expression in Gastric Cancer by 64Cu-NOTA-Trastuzumab in PDX Mouse Model and in Patients. Molecular Pharmaceutics. 2018, 15 (11), 5174–5182 (SCI IF 4.556 Q1 )
6. C Liu, TL Liu, N Zhang, YQ Liu, N Li, P Du, Y Yang, M Liu, K Gong, X Yang, H Zhu*, K Yan, Z Yang*. 68Ga-PSMA-617 PET/CT: a promising new technique for predicting risk stratification and metastatic risk of prostate cancer patients. European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45(11): 1852–1861. (SCI IF 7.7, Q1)
7. F Liu, TL Liu; XX Xu, XY Guo, N Li, CY Xiong, C Li, H Zhu*, Z Yang*. Design, Synthesis and Biological Evaluation of 68Ga-DOTA-PA1 for Lung Cancer: A Novel PET Tracer for Multiple Somatostatin Receptors Imaging. Molecular Pharmaceutics. 2018. 15, 619−628. (SCI IF 4.4).
8. Xie QH†, Zhu H†, Wang F, Meng XX, Ren QS, Xia CQ *, Yang Z*.Establishing Reliable 64Cu Production Process: From Target Plating to Molecular Specific Tumor Micro-PET Imaging. Molecules 2017, 22, 641. (SCI IF 2.86)
9. Hua Zhu†, Chuanke Zhao†, Fei Liu, Lixin Wang, Junnan Feng, Chengchao Shou*, Zhi Yang*. 125I-F56 peptide as radio-analysis agent targeting VEGFR1 in mice xenografted with human gastric tumor. ACS Med. Chem. Lett. 2017, 8, 266-269. (SCI IF 3.74) (20170120)
10. Wu Y†, Zhu H†, Zhang B, Liu F, Chen J, Wang Y, Wang Y, Zhang Z, Wu L, Si L, Xu H, Yao T, Xiao S, Xia Q, Zhang L, Yang Z*, Zhou D*. Synthesis of Site-Specific Radiolabeled Antibodies for Radioimmunotherapy via Genetic Code Expansion. Bioconjug Chem. 2016, 27(10), 2460–2468. († Equal Contribution) (IF 4.5, 20160912)
展开全部
发表论文情况
近3年代表性论文(10 篇)：( †代表共同第一作者，*代表通讯作者)
1. Hua Zhu, Liu Fei, Yan Zhang, Jianhua Yang, Xiaoxia Xu, Xiaoyi Guo, Teli Liu, Nan Li, Lin Zhu, Hank F. Kung*, Zhi Yang*. [18F](2S,4R)-4-Fluoroglutamine as a PET indicator for bone marrow metabolism dysfunctional: From animal experiments to clinical application. Molecular Imaging and Biology. 2019. DOI: 10.1007/s11307-019-01319-4. (Q1, SCI 3.626)
2. Teli Liu†, Chen Liu†, Xiaoxia Xu, Fei Liu, Xiaoyi Guo, Nan Li, Xuejuan Wang, Jianhua Yang, Xing Yang, Hua Zhu*, Zhi Yang*. Preclinical evaluation and primary clinical study of Al18F-PSMA-BCH in PET imaging of prostate cancer. Journal of Nuclear Medicine, 2019, doi:10.2967/jnumed.118.221671. (Q1, SCI 7.439)
3. Fei Liu†, Xiaoxia Xu†, Hua Zhu†, Yan Zhang, Jianhua Yang, Lifang Zhang, Nan Li, Lin Zhu, Hank F. Kung*, Zhi Yang*. PET Imaging of 18F-(2S,4R)4-fluoroglutamine Accumulation in Breast Cancer: from Xenografts to Patients. Molecular Pharmaceutics. 2018, 15 (8), pp 3448-3455. (SCI IF 4.556 Q1 )
4. Feng Wang, Teli Liu, Liqiang Li, Xiaoyi Guo, Dongban Duan, Zhibo Liu, Hua Zhu*, Zhi Yang. Production, Quality Control of next-generation PET radioisotope Iodine-124 and its Thyroid Imaging. J Radio. Nucl. Chem. 2018, 318: 1999-2006. (SCI IF 1.2, Q2)
5. Xiaoyi Guo†, Hua Zhu†, Nina Zhou, Zuhua Chen, Teli Liu, Fei Liu, Xiaoxia Xu, Hongjun Jin, Lin Shen, Jing Gao*, and Zhi Yang*.Non-invasive Detection of HER2 Expression in Gastric Cancer by 64Cu-NOTA-Trastuzumab in PDX Mouse Model and in Patients. Molecular Pharmaceutics. 2018, 15 (11), 5174–5182 (SCI IF 4.556 Q1 )
6. C Liu, TL Liu, N Zhang, YQ Liu, N Li, P Du, Y Yang, M Liu, K Gong, X Yang, H Zhu*, K Yan, Z Yang*. 68Ga-PSMA-617 PET/CT: a promising new technique for predicting risk stratification and metastatic risk of prostate cancer patients. European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45(11): 1852–1861. (SCI IF 7.7, Q1)
7. F Liu, TL Liu; XX Xu, XY Guo, N Li, CY Xiong, C Li, H Zhu*, Z Yang*. Design, Synthesis and Biological Evaluation of 68Ga-DOTA-PA1 for Lung Cancer: A Novel PET Tracer for Multiple Somatostatin Receptors Imaging. Molecular Pharmaceutics. 2018. 15, 619−628. (SCI IF 4.4).
8. Xie QH†, Zhu H†, Wang F, Meng XX, Ren QS, Xia CQ *, Yang Z*.Establishing Reliable 64Cu Production Process: From Target Plating to Molecular Specific Tumor Micro-PET Imaging. Molecules 2017, 22, 641. (SCI IF 2.86)
9. Hua Zhu†, Chuanke Zhao†, Fei Liu, Lixin Wang, Junnan Feng, Chengchao Shou*, Zhi Yang*. 125I-F56 peptide as radio-analysis agent targeting VEGFR1 in mice xenografted with human gastric tumor. ACS Med. Chem. Lett. 2017, 8, 266-269. (SCI IF 3.74) (20170120)
10. Wu Y†, Zhu H†, Zhang B, Liu F, Chen J, Wang Y, Wang Y, Zhang Z, Wu L, Si L, Xu H, Yao T, Xiao S, Xia Q, Zhang L, Yang Z*, Zhou D*. Synthesis of Site-Specific Radiolabeled Antibodies for Radioimmunotherapy via Genetic Code Expansion. Bioconjug Chem. 2016, 27(10), 2460–2468. († Equal Contribution) (IF 4.5, 20160912)
- 查看朱华医生出诊时间 医生号源排班实时学握，预约挂号快人一步
- 立即预约
出诊信息
更多去哪找朱华医生看病
-
出诊医院地址
北京海淀区阜成路52号（定慧寺）
-
医院门诊时间
-
-
医院咨询电话
010-88121122
-
地址与交通
1.机场路线：展开全部
机场距离医院大约40公里左右，你可以选择的交通方式：
（1）出租车：目的地为北京肿瘤医院（西三环定慧寺），费用约110元左右，上下波动取决于北京市的交通流量；
（2）机场大巴：3号路线：首都机场—公主坟，8:00-23:00，票价16元，每30分钟一趟，于航天桥站下车，转乘公交两站到达定慧寺下车，可转乘的路线可有56、121、336、603、612、运通106等多条线路；
（3）公交换乘：从首都机场出发,乘坐359路(东直门-首都机场),在东直门换乘地铁2号线至阜城门站，转乘公交121、56、336、603、746、612、运通106等定慧寺站下车即到。
2.北京西站路线
西站距离医院大约6公里左右，你可以选择的交通方式：
(1)出租车：目的地为北京肿瘤医院（西四环定慧寺），费用约16元左右，上下波动取决于北京市的交通流量；
(2)公交换乘：出站后站前广场乘转乘公交40、414、89、854及运通102、202等定慧寺站下车即到。
3.北京站路线
北京站距离医院大约15公里左右，你可以选择的交通方式：
(1)出租车：目的地为北京肿瘤医院（西四环定慧寺），费用约45元左右，上下波动取决于北京市的交通流量；
(2)公交换乘：出站后站前广场乘地铁2号线，或公交103电车至阜城门站，转乘公交121、56、336、603、746、612、运通106等定慧寺站下车即到。